XML 36 R22.htm IDEA: XBRL DOCUMENT v3.7.0.1
Significant Accounting Policies (Details)
1 Months Ended 3 Months Ended 6 Months Ended
Apr. 24, 2017
$ / shares
shares
Nov. 22, 2016
USD ($)
May 31, 2017
USD ($)
Mar. 31, 2017
USD ($)
Jun. 30, 2017
USD ($)
$ / shares
shares
Apr. 23, 2017
shares
Jan. 01, 2017
USD ($)
Dec. 31, 2016
$ / shares
shares
Reverse stock split, description         1-for-10 (1:10) reverse stock split of its common stock, par value $0.01 per share      
Conversion ratio of reverse stock split 10              
Common stock, shares authorized | shares 67,000,000       67,000,000 670,000,000   67,000,000
Common stock, par value (in dollars per share) | $ / shares $ 0.01       $ 0.01     $ 0.01
Total market capitalization         $ 6,700,000      
Increase in APIC and accumulated deficit resulting from newly adopted policy             $ 8,000  
Public Offering of Warrants and Common Stock [Member]                
Proceeds from equity offerings, gross   $ 4,000,000 $ 10,600,000          
Pseudomonas Program [Member]                
Research and development in process       $ 5,300,000 1,900,000      
Staph Program [Member]                
Research and development in process       $ 5,200,000 2,800,000      
In Process Research and Development [Member]                
Impairment of in process research and development         5,800,000      
Income tax expense (benefit) related to IPR&D impairment         $ (1,300,000)